Inventor · disambiguated record
Miguel St-Onge
Also filed as: ST-ONGE MIGUEL
4 granted patents·11 pending applications·0 citations·filing 2013–2025
60Inventor score
Top patents by PatentIndex Score
15 records- 0187US2025250270A1Compounds for inhibiting nlrp3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2024·Application pending·0 cites
- 0286US12410167B2Pyridazine compounds for inhibiting NLRP3VENTUS THERAPEUTICS U S INC·Filed 2023·Granted Sep 9, 2025·0 cites·17 claims
- 0385US2024158396A1Compounds for inhibiting nlrp3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2023·Application pending·0 cites
- 0481US12351578B2Compounds for inhibiting NLRP3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2022·Granted Jul 8, 2025·0 cites·20 claims
- 0577US2022340567A1Compounds for inhibiting nlrp3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2022·Application pending·0 cites
- 0665US2024368131A1Oxoindolinyl amide derivatives for inhibiting nlrp3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2024·Application pending·0 cites
- 0758US2025002487A1Heterocyclic compounds and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2022·Application pending·0 cites
- 0854US2024018138A1PYRIDO[4,3-b]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALSVENTUS THERAPEUTICS U S INC·Filed 2021·Application pending·0 cites
- 0951US12264155B2Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as ATR kinase inhibitorsREPARE THERAPEUTICS INC·Filed 2021·Granted Apr 1, 2025·0 cites·23 claims
- 1046US2025179070A1Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as atr kinase inhibitorsREPARE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1146US2019119282A1Imidazopyridazines useful as inhibitors of the par-2 signaling pathwayVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 1245US2013296382A1Non-nucleoside reverse transcriptase inhibitorsMERCK CANADA INC·Filed 2013·Application pending·0 cites
- 1344US2022185809A1Substituted 2-morpholinopyridine derivatives as atr kinase inhibitorsREPARE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1441US10030024B2Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathwayVERTEX PHARMA·Filed 2016·Granted Jul 24, 2018·0 cites·23 claims
- 1531US2018057505A1Bicyclic heteroaryl compounds useful as inhibitors of the par-2 signaling pathwayVERTEX PHARMA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Miguel St-Onge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →